未登录

J

Jill M. Steinbach-Rankins

Yale University

H指数:20

被引数:1,156

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aligning biopharma and academic partnerships to advance drug delivery technologies: insights from a multidisciplinary panel

整合生物制药与学术合作关系以推动药物递送技术：来自跨学科小组的见解

Drug Delivery and Translational Research

IF5.5

2026-09-090

PRE

Application of a UV-vis spectrometer to investigate the effect of dissolution media on the diffusivity of small molecules and proteins

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2025-01-010

OAAI

Mesh and layered electrospun fiber architectures as vehicles for Lactobacillus acidophilus and Lactobacillus crispatus intended for vaginal delivery

网状和分层电纺纤维结构可作为嗜酸乳杆菌和卷曲乳杆菌的载体，用于阴道分娩

BIOMATERIALS ADVANCES

IF6

2023-11-012

OAAI

Development and Characterization of Lactobacillus rhamnosus -Containing Bioprints for Application to Catheter-Associated Urinary Tract Infections

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2023-06-2711

PRE

Formulation and characterization of pressure-assisted microsyringe 3D-printed scaffolds for controlled intravaginal antibiotic release

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-06-019

OAAI

A Novel, Nitric Oxide-Releasing Elastomeric Chain for Antimicrobial Action

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2022-11-010

PRE

Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments

IF5.5

2021-11-086

OAAI

Perspectives on Existing and Novel Alternative Intravaginal Probiotic Delivery Methods in the Context of Bacterial Vaginosis Infection

IF3.7

2021-05-1018

OA

In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2021-02-016

OAAI

Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms

IF5.5

2020-09-013

OAAI

Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2020-05-2113

OA

Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-05-0129

OAAI

Rapid Release Polymeric Fibers for Inhibition of Porphyromonas gingivalis Adherence to Streptococcus gordonii

FRONTIERS IN CHEMISTRY

IF4.2

2020-01-2111

OAAI

Surface-Modified Melphalan Nanoparticles for Intravitreal Chemotherapy of Retinoblastoma

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

IF4.7

2019-04-2227

OAAI

Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications

IF5.5

2019-04-0311

OAAI

Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type

PHARMACEUTICAL RESEARCH

IF4.3

2019-03-1314

OAAI

Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target

MOLECULAR CANCER THERAPEUTICS

IF5.5

2019-02-049

OA

BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2018-09-1514

OAAI

Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2018-05-017

OAAI

Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2017-10-0120

OAAI